I move on mah ... keyman no move on mah ... so understand ?? or are you still confuse ?? NVM i come out $$ for you to see a brain soc to make you more clever .... hehe

Come lets debunk the old news :-

Budget passed without windfall tax - done deal !! no worries

TG Ipoh to face Saman and suspension - do you see any news ?? Consider goner !!

Management fund run short for sbb and epf selling - We all know management is still buying and EPF bought back 9mils

Vaccine deployment- Hai ya ... you know I know this will last till 2022 and beyond so glove still in high demand!!

So keyman ... you can move on liao mah ?? or you want to stuck in your old story and continue your sad life !! Wakaka ...

Hai yo ... alot of theory and prediction !! Who belive you stockraider ?? Dont sinkalin with your fail theory la ... Go read the news from Tan Sri !!
Between, whatever Tan Sri promised, Tan Sri always achieved !!
But for you, everything also miss que !! No wonder... you dont dare to put your real name !! I understand ~~ wakaka

Hai yah ... Keyman !! Sound like you are really bitter and sour !!
To you, anyone who is still holding and is defending the glove industry; is a victim ... why do you have that thought ??
Dont tell me you are a living example that got burned and lost your saving ... Pitiful!! No wonder... you are so sore and so active in gloating other !! Kesian nya keyman ... Now cannot move on and keep on repeating old story to make yourself feel better ~~
If it make you feel better, continue your sad life !! Wakaka

Hai yah ... Keyman !! Sound like you are really bitter and sour !!
To you, anyone who is still holding and is defending the glove industry; is a victim ... why do you have that thought ??
Dont tell me you are a living example that got burned and lost your saving ... Pitiful!! No wonder... you are so sore and so active in gloating other !! Kesian nya keyman ... Now cannot move on and keep on repeating old story to make yourself feel better ~~
If it make you feel better, continue your sad life !! Wakaka

Yeah right !! Why dont you use RM 5400 and grow it to become RM1.47 M in 19 years !! Follow your technical ... see how far you go !! It is a challenge !!

After all this years since the initial IPO... Top Glove have multiple warrants, goes through H1N1, SARS, Swine Flu and 08/09 financial crisis ... The price still remained solid !! The long timers who bought 2 lots had became millinonaire now !! So you tell me why are you so worry about the IB and warrants now ??

TopGlove IPO price RM2.70 March 2001

2,000 units X RM2.70= RM5,400

Bonus issues:
2002 3:10 ==> 2,600 units
2003 2:5 ==> 3,640 units
2005 1:1 ==> 7,280 units
2007 2:5 ==> 10,192 units
2010 1:1 ==> 20,384 units
2016 1:1 ==> 40,768 units
2018 1:1 ==> 81,536 units
2020 2:1 ==> 244,608 units

244608 units X RM6.120 = RM 1,497,000

Trust this chart tell everything ~~

FYI... in case you worried about the gloves demand will dropped after Covid & Top Glove after the “supernormal profit”

https://www.klsescreener.com/v2/news/view/773059/glove-makers-in-for-a...

Please dont be mistaken about glove demand !! If you dont read the news, you better dont buy share ~~

https://www.thestar.com.my/business/business-news/2020/12/17/global-de...

https://www.nst.com.my/business/2020/12/651655/global-rubber-glove-sho...

https://www.theedgemarkets.com/article/covid19-rhb-says-vaccine-deploy...

https://www.globenewswire.com/news-release/2020/12/16/2146280/0/en/Glo...

Overall review:-

EPF interested in buying again with ESG fulfillment
Crossed buying from recovery market sell off
Covid mutation in UK, may lead to potential epidemic
Vaccine faced production capacity limitation
Vaccine faced distribution issue
Vaccine had allergy effect
Vaccine do not have testing for long term side effect
Vaccine not recommended for under 16
Vaccine not recommended for pregnant mom
Covid to spike from now till end of Feb
ASP for glove to rise 20-30% in this quarter
Order in hand for FY21 and FY22 still in tag
Record breaking RM 3.5B PAT coming QR
Additional 10% capacity in the coming quarter
Worker act issue and accomodation to be settle this month
US Ban in final discussion, expected to be resume export in Jan
Management continue to buy in and provide support line
Glove demand expected to rise by 20-30% in FY21
Divident at least 8% for FY21 with the current price

TG next quarter review:-

ESG fulfillment will prompt EPF acquisition
Additional 10% capacity = Increased Revenue
ASP to rises 20-30% = Approximately RM 3.5Billion PAT
Worker Accomodation to be settled in Jan
US Ban in final stages of discussion, should be lifted in FY21Q2
Demand for glove expected to rise 20-30% in FY21
Remained as a safe haven from political uncertainy
Remained as favourite to capitalise in Covid spike
Next dividend should be more than 16.5sen due to increased Revenue and PAT

The fact is Covid 19 cases continue to spiked in 2021 and the vacination proccess unable to cope with. Glove demand expected to soar and faced shortage till March at least. Guess which sector will thrive during all of this ?? You got a record breaking FY21 ahead and order already in hand... even the not so smart know to invest in glove!!

Beside RSS set to resumed in 2021, Trust the most effected would be the recovery market when optimism ran short and reality set in. When people realise that the market will need longer time to recover and the figure in the statement does not justify the price. Crossed buy will happen, where do you think they will transfer the fund too?? The safe haven remained in glove industry!!

Last but not least, Nay Sayer had been really active now, which can only mean they are desperate to come in!! They also know the glove sector will be really attractive in FY21 and will try their best to come in cheap at the expense of weak share holders!! In order to buy cheap, someone need to sell cheap, right ??


https://www.wsj.com/livecoverage/covid-2020-12-31

https://www.thestar.com.my/news/nation/2020/12/31/covid-19-record-high...

https://www.nst.com.my/business/2020/12/651655/global-rubber-glove-sho...

Research done before pandemic :-

Insights on the Global Medical Gloves Industry to 2025 - Key Drivers, Trends and Restraints


June 04, 2020 07:33 ET | Source: Research and Markets
Dublin, June 04, 2020 (GLOBE NEWSWIRE) -- The "Medical Gloves Market - Global Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.

The medical gloves market is expected to grow at a CAGR of over 15% during the period 2019-2025.

The global medical gloves market is growing at a healthy rate. The growth can be attributed to the growing demand for safety and hygiene standards to prevent the risk of contamination and infections in healthcare settings during medical and treatment measures. The growth in surgical procedures for several diseases and potential risk reduction for surgical site infection (SSI) is likely to fuel the market growth.

Health care professionals will continue to demand the latest medical gloves to treat acute and chronic diseases, which will promote safe and effective treatment outcomes. The emergence of new pandemic challenges such as COVID-19 will drive the future growth of the market. A strong preference for non-powdered medical gloves is also likely to drive future market growth.

The following factors are likely to contribute to the growth of the medical gloves market during the forecast period:

Emergence of New Pandemic Challenge
Progressive Emphasis on Stringent Health Regulations across Regions
Increased Focus on Safety and Hygiene Standards
Growth in Surgical Procedures
The study considers the present scenario of the medical gloves market and its market dynamics for the period 2019-2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspect of the market. It profiles and examines leading companies and other prominent ones operating in the market. The research report covers the market in terms of revenue and volume forecast.

Key Questions Answered

What is the market size of the medical gloves market?
What are the factors impacting the growth of the disposable gloves market?
What are the drivers, trends, and restraints in the market?
Who are the leading vendors in the surgical gloves market and what are their market shares?
What is the impact of the COVID-19 pandemic on the surgical gloves market?
This research report includes a detailed segmentation by Material, Application, Category, End-user, and geography. The nitrile gloves segment is expected to grow at a healthy CAGR during the forecast period. The demand for nitrile gloves is increasing due to the number of benefits, including alleviating allergies and increased chemical and puncture resistance. Manufacturers are preparing nitrile ones as comfortable as latex with improved quality. Hence, manufacturers are increasingly focusing on developing a new type of accelerator-free nitrile gloves. They contain less chemicals and are stronger than traditional nitrile ones without compromising comfort. With the ongoing shift from latex to nitrile, manufacturers reported high sales from nitrile gloves in 2019.

The North American market is expected to grow at a CAGR of over 15% during the period 2019-2025. The region is characterized by high penetration of advanced treatment solutions for chronic and acute diseases, advancements in material such as latex-free non-allergic gloves. With the favorable government financial support for several surgical procedures results in the higher uptake of surgeries as well as surgical gloves.

North America offers tremendous growth opportunities; therefore, the market is expected to continue to grow during the upcoming period. The US is the major revenue contributor to the global market. The country holds the highest value due to better healthcare facilities and medical coverage and spending. The US medical gloves market is growing at a significant rate and is likely to grow during the forecast period.

The global medical gloves market share is very fragmented and is highly competitive, and dynamic characterized by the presence of many global, regional, and local vendors. The vendors are offering a diverse range of medical gloves for both examination and surgical applications. Large and diversified companies accounts for major shares. Also, most key players - Top Glove, Ansell, Kossan Rubber Industries, Hartalega Holdings, Supermax - have demonstrated consistent growth over the last few years.

https://www.globenewswire.com/news-release/2020/06/04/2043617/0/en/Insights-on-the-Global-Medical-Gloves-Industry-to-2025-Key-Drivers-Trends-and-Restraints.html

Please dont be mistaken about glove demand !! If you dont read the news, you better dont buy share ~~

https://www.thestar.com.my/business/business-news/2020/12/17/global-de...

https://www.nst.com.my/business/2020/12/651655/global-rubber-glove-sho...

https://www.theedgemarkets.com/article/covid19-rhb-says-vaccine-deploy...

https://www.globenewswire.com/news-release/2020/12/16/2146280/0/en/Glo...

FYI... in case you worried about the gloves demand will dropped after Covid & Top Glove after the “supernormal profit”

https://www.klsescreener.com/v2/news/view/773059/glove-makers-in-for-a-good-run-this-year

After all this years since the initial IPO... Top Glove have multiple warrants, goes through H1N1, SARS, Swine Flu and 08/09 financial crisis ... The price still remained solid !! The long timers who bought 2 lots had became millinonaire now !! So you tell me why are you so worry about the IB and warrants now ??

That is where fundamental played a big part and Intrinsic Value applied !!
Dont get me wrong, but there will be up and down ... In the end, it will still returned to its IV

Between, when you are a investor... you dont put your fund on warrants!! That is only for gambler ...
Investor will placed their fund on the mother share ~~ Bescause that is the most reliable!!

TopGlove IPO price RM2.70 March 2001

2,000 units X RM2.70= RM5,400

Bonus issues:
2002 3:10 ==> 2,600 units
2003 2:5 ==> 3,640 units
2005 1:1 ==> 7,280 units
2007 2:5 ==> 10,192 units
2010 1:1 ==> 20,384 units
2016 1:1 ==> 40,768 units
2018 1:1 ==> 81,536 units
2020 2:1 ==> 244,608 units

244608 units X RM6.120 = RM 1,497,000

Trust this chart tell everything ~~

Trust for the warrants fear factor and IB manipulation is to create panic selling!!
Every big company will have this but all this will be overlooked if the fundamental is stong enough!! In the end, the Intrinsic Value will prevail!!
FYI, Warren Buffet do not look or bother about all the warrants or IB manupulation on his company... He only look at the fundamental and intrinsic value; And this is how he grow to become the TOP 5 richest man in the world !!

When demands went up, the price went up !! That justified FY 21 order increment !! Everything goes in a cycle, right ?

Vaccine Legel Immunity... If you got side effect or dies due to vaccination, you cant sue the manufacturer or the government!! That tell alot !!

https://www.cnbc.com/2020/12/16/covid-vaccine-side-effects-compensation-lawsuit.html

https://www.independent.co.uk/news/health/coronavirus-pfizer-vaccine-legal-indemnity-safety-ministers-b1765124.html

Covid variant which can be easily transmit is now on 32 countries~~
https://www.nytimes.com/live/2021/01/01/world/covid-19-coronavirus-updates

This is only the short term side effect, the long term side effect is yet to known due to only a few monthes testing result!!

https://www.nbcdfw.com/news/coronavirus/dr-explains-possible-temporary-side-effects-to-covid-19-vaccine-more-prevalent-among-younger-adults/2517693/

Vaccine fears is real and the side effect is not fake :-

https://www.dailymail.co.uk/health/article-9104845/Up-60-health-workers-refusing-COVID-19-vaccines.html

Trust Glove is consider as an essential products in which will be given priority in term of shipment!! So there wont be much delay or congestion for shipping !! Beside, Glove quantity for hospital around the world is running short due to the covid spike... countries on the receiving had prioritise glove shipment too!!

The list is increasing for the covid variant:-

https://www.aljazeera.com/news/2020/12/31/which-countries-have-reported-new-variants-of-covid-19

The fact is Covid 19 cases continue to spiked in 2021 and the vacination proccess unable to cope with. Glove demand expected to soar and faced shortage till March at least. Guess which sector will thrive during all of this ?? You got a record breaking FY21 ahead and order already in hand... even the not so smart know to invest in glove!!

Beside RSS set to resumed in 2021, Trust the most effected would be the recovery market when optimism ran short and reality set in. When people realise that the market will need longer time to recover and the figure in the statement does not justify the price. Crossed buy will happen, where do you think they will transfer the fund too?? The safe haven remained in glove industry!!

Last but not least, Nay Sayer had been really active now, which can only mean they are desperate to come in!! They also know the glove sector will be really attractive in FY21 and will try their best to come in cheap at the expense of weak share holders!! In order to buy cheap, someone need to sell cheap, right ??


https://www.wsj.com/livecoverage/covid-2020-12-31

https://www.thestar.com.my/news/nation/2020/12/31/covid-19-record-high...

https://www.nst.com.my/business/2020/12/651655/global-rubber-glove-sho...

Top Glove latest:-
https://www.thestar.com.my/business/business-news/2021/01/02/glove-makers-in-for-a-good-run-this-year

https://www.klsescreener.com/v2/news/view/773059/glove-makers-in-for-a-good-run-this-year

Please dont be mistaken about glove demand !! If you dont read the news, you better dont buy share ~~

https://www.thestar.com.my/business/business-news/2020/12/17/global-de...

https://www.nst.com.my/business/2020/12/651655/global-rubber-glove-sho...

https://www.theedgemarkets.com/article/covid19-rhb-says-vaccine-deploy...

https://www.globenewswire.com/news-release/2020/12/16/2146280/0/en/Glo...

TG next quarter review:-

ESG fulfillment will prompt EPF acquisition
Additional 10% capacity = Increased Revenue
ASP to rises 20-30% = Approximately RM 3.5Billion PAT
Worker Accomodation to be settled in Jan
US Ban in final stages of discussion, should be lifted in FY21Q2
Demand for glove expected to rise 20-30% in FY21
Remained as a safe haven from political uncertainy
Remained as favourite to capitalise in Covid spike
Next dividend should be more than 16.5sen due to increased Revenue and PAT

Overall review:-

EPF interested in buying again with ESG fulfillment
Crossed buying from recovery market sell off
Covid mutation in UK, may lead to potential epidemic
Vaccine faced production capacity limitation
Vaccine faced distribution issue
Vaccine had allergy effect
Vaccine do not have testing for long term side effect
Vaccine not recommended for under 16
Vaccine not recommended for pregnant mom
Covid to spike from now till end of Feb
ASP for glove to rise 20-30% in this quarter
Order in hand for FY21 and FY22 still in tag
Record breaking RM 3.5B PAT coming QR
Additional 10% capacity in the coming quarter
Worker act issue and accomodation to be settle this month
US Ban in final discussion, expected to be resume export in Jan
Management continue to buy in and provide support line
Glove demand expected to rise by 20-30% in FY21
Divident at least 8% for FY21 with the current price

TopGlove IPO price RM2.70 March 2001

2,000 units = RM5,400

Bonus issues:
2002 3:10 ==> 2,600 units
2003 2:5 ==> 3,640 units
2005 1:1 ==> 7,280 units
2007 2:5 ==> 10,192 units
2010 1:1 ==> 20,384 units
2016 1:1 ==> 40,768 units
2018 1:1 ==> 81,536 units
2020 2:1 ==> 244,608 units

244608 units = RM 1,497,000

This chart tell everything... From a few tousand to a millionaire for loyal holders
Dont forget that the company also give dividends yearly, so the figure is more !!

I dont know bro ....

Alamak ... keyman kena questioned kaw kaw !! Granpa keyman panicky now, dont get heart attack arr !!

Dont la ... question grandpa keyman like that !! He lonely old man who dont have anyone one ... He just want attention mah ... At least here, got people chat with him .... Kesian la him

Grandpa keyman remember me ... I very proud that someone remember me !! Somemore call me sifu !! On cloud 9 now LOL

Granpa keyman is here ... tell us your old repeat story again !! Cause granpa have bad memory and dont read the news anymore... only remeber old news !! Wkakaa

Very clever ... that 9 mils is under SBL and is not bought by EPF la !!
So you mean EPF did not dispose recently la ?? but sold to IB for shorting la ...
Like this, then IB will need continue to SBL next week until EPF got their 5.8% again !! Like that ... huat la !! Everyday limit up liao next week !!

Not forgetting next week Top Glove Annual General Meeting !! All the long timer will know there is always great news announcement during the meeting !! Get ready to go up to RM9 again !!

If all of this warrants and IB thingy is so influential!! Then how come all the holders from the start became millionaire now ??
Just dont get trick by all this con artist who try to create a panic selling so that they can buy your cheap units !!

Trust for the warrants fear factor and IB manipulation is to create panic selling!!
Every big company will have this but all this will be overlooked if the fundamental is stong enough!! In the end, the Intrinsic Value will prevail!!
FYI, Warren Buffet do not look or bother about all the warrants or IB manupulation on his company... He only look at the fundamental and intrinsic value; And this is how he grow to become the TOP 5 richest man in the world !!

TopGlove IPO price RM2.70 March 2001

2,000 units = RM5,400

Bonus issues:
2002 3:10 ==> 2,600 units
2003 2:5 ==> 3,640 units
2005 1:1 ==> 7,280 units
2007 2:5 ==> 10,192 units
2010 1:1 ==> 20,384 units
2016 1:1 ==> 40,768 units
2018 1:1 ==> 81,536 units
2020 2:1 ==> 244,608 units

244608 units = RM 1,497,000

This chart tell everything... From a few tousand to a millionaire for loyal holders
Dont forget that the company also give dividends yearly, so the figure is more !!

TopGlove IPO price RM2.70 March 2001

2,000 units = RM5,400

Bonus issues:
2002 3:10 ==> 2,600 units
2003 2:5 ==> 3,640 units
2005 1:1 ==> 7,280 units
2007 2:5 ==> 10,192 units
2010 1:1 ==> 20,384 units
2016 1:1 ==> 40,768 units
2018 1:1 ==> 81,536 units
2020 2:1 ==> 244,608 units

Not forgetting company yearly dividend!! From a few thousand to a millionaire now !!

The fact is Covid 19 cases continue to spiked in 2021 and the vacination proccess unable to cope with. Glove demand expected to soar and faced shortage till March at least. Guess which sector will thrive during all of this ?? You got a record breaking FY21 ahead and order already in hand... even the not so smart know to invest in glove!!

Beside RSS set to resumed in 2021, Trust the most effected would be the recovery market when optimism ran short and reality set in. When people realise that the market will need longer time to recover and the figure in the statement does not justify the price. Crossed buy will happen, where do you think they will transfer the fund too?? The safe haven remained in glove industry!!

Last but not least, Nay Sayer had been really active now, which can only mean they are desperate to come in!! They also know the glove sector will be really attractive in FY21 and will try their best to come in cheap at the expense of weak share holders!! In order to buy cheap, someone need to sell cheap, right ??


https://www.wsj.com/livecoverage/covid-2020-12-31

https://www.thestar.com.my/news/nation/2020/12/31/covid-19-record-high...

https://www.nst.com.my/business/2020/12/651655/global-rubber-glove-sho...

Please dont be mistaken about glove demand !! If you dont read the news, you better dont buy share ~~

https://www.thestar.com.my/business/business-news/2020/12/17/global-de...

https://www.nst.com.my/business/2020/12/651655/global-rubber-glove-sho...

https://www.theedgemarkets.com/article/covid19-rhb-says-vaccine-deploy...

https://www.globenewswire.com/news-release/2020/12/16/2146280/0/en/Glo...

Overall review:-

EPF interested in buying again with ESG fulfillment
Crossed buying from recovery market sell off
Covid mutation in UK, may lead to potential epidemic
Vaccine faced production capacity limitation
Vaccine faced distribution issue
Vaccine had allergy effect
Vaccine do not have testing for long term side effect
Vaccine not recommended for under 16
Vaccine not recommended for pregnant mom
Covid to spike from now till end of Feb
ASP for glove to rise 20-30% in this quarter
Order in hand for FY21 and FY22 still in tag
Record breaking RM 3.5B PAT coming QR
Additional 10% capacity in the coming quarter
Worker act issue and accomodation to be settle this month
US Ban in final discussion, expected to be resume export in Jan
Management continue to buy in and provide support line
Glove demand expected to rise by 20-30% in FY21
Divident at least 8% for FY21 with the current price

TG next quarter review:-

ESG fulfillment will prompt EPF acquisition
Additional 10% capacity = Increased Revenue
ASP to rises 20-30% = Approximately RM 3.5Billion PAT
Worker Accomodation to be settled in Jan
US Ban in final stages of discussion, should be lifted in FY21Q2
Demand for glove expected to rise 20-30% in FY21
Remained as a safe haven from political uncertainy
Remained as favourite to capitalise in Covid spike
Next dividend should be more than 16.5sen due to increased Revenue and PAT

Dont blast their balls le ... they want to shiok sendiri mah !! Wakaka